EXPANDING ACCESS TO CAR-T THERAPIES: OVERCOMING BARRIERS AND DRIVING ADOPTION
{Salone dei Cavalieri, Section 3&4}
11:30am – 12:15pm
This panel will address the barriers preventing broader access to CAR-T therapies, such as logistical, financial, and regulatory challenges. Experts will share insights on how to drive adoption and improve patient access to these transformative treatments.
Moderator:
Rupa Pike, Ph.D., Senior Director and Global Head of Strategic Alliances, Catalent
Speakers:
David Fontana, Ph.D., Chief Operations Officer and Chief Business Officer, Umoja Biopharma
Phung Osborn, Vice President, Head of Global Market Access, Cell Therapy, Bristol Myers Squibb
Dilip Patel, Senior Vice President, Pricing and Market Access Strategy, Autolus
Panteli Theocharous, Ph.D., FRCPath, Chief Therapeutics Officer, Head of Medical and Scientific Affairs, Garuda Therapeutics